Okabena Investment Services’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Okabena Investment Services’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-23,518	Closed	-$708K	–	157
2026 Q1	$708K	Buy	+23,518	New	+$757K	0.14%	95
2025 Q3	–	Sell	-31,944	Closed	-$535K	–	145
2025 Q2	$535K	Buy	31,944 +1,703	+6%	+$27.5K	0.12%	97
2025 Q1	$465K	Sell	30,241 -6,209	-17%	-$111K	0.12%	100
2024 Q4	$803K	Sell	36,450 -22,326	-38%	-$406K	0.22%	73
2024 Q3	$1.06M	Buy	+58,776	New	+$1.03M	0.3%	62

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Okabena Investment Services's TEVA Position: Q2 2026 in Review

Okabena Investment Services sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2026, closing a stake of 23,518 shares — an estimated $708K sold.

Okabena Investment Services first reported a position in TEVA in Q3 2024 and held it in 5 quarters. The position peaked at $1.06M in Q3 2024. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Okabena Investment Services reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2026 after selling out during the quarter.
Okabena Investment Services sold 23,518 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $708K.
Okabena Investment Services first reported a position in Teva Pharmaceutical Industries Limited in Q3 2024 and held it in 5 quarters.
Okabena Investment Services's Teva Pharmaceutical Industries Limited position peaked at $1.06M in Q3 2024.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Okabena Investment Services's 13F filing for Q2 2026, filed 4 Aug 2026.